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Achieving long-term retroviral expression in primary cells has been problematic. De novo DNA methylation
of infecting proviruses has been proposed as a major cause of this transcriptional repression. Here we report
the development of a mouse stem cell virus (MSCV) long terminal repeat-based retroviral vector that is
expressed in both embryonic stem (ES) cells and hematopoietic stem (HS) cells. Infected HS cells and their
differentiated descendants maintained long-term and stable retroviral expression after serial adoptive trans-
fers. In addition, retrovirally infected ES cells showed detectable expression level of the green fluorescent
protein (GFP). Moreover, GFP expression of integrated proviruses was maintained after in vitro differentiation
of infected ES cells. Long-term passage of infected ES cells resulted in methylation-mediated silencing, while
short-term expression was methylation independent. Tissues of transgenic animals, which we derived from ES
cells carrying the MSCV-based provirus, did not express GFP. However, treatment with the demethylating
agent 5-azadeoxycytidine reactivated the silent provirus, demonstrating that DNA methylation is involved in
the maintenance of retroviral repression. Our results indicate that retroviral expression in ES cells is
repressed by methylation-dependent as well as methylation-independent mechanisms.
Retroviral vectors are appealing vehicles for gene transfer.
However, long-term expression mediated by integrated provi-
ruses in primary cells has been difficult to achieve. Retroviral
regulatory elements are repressed in numerous cell types, in-
cluding embryonic stem (ES) cells and hematopoietic stem
(HS) cells (1, 3). For example, vectors that are functional in
mature hematopoietic cells are often not expressed in blood
cells of animals transplanted with the infected stem cells (18,
19, 31). In particular, the lack of significant provirus transcrip-
tion in ES cells and their differentiated descendants has ham-
pered the use of retroviral vectors in transgenic experiments (5,
12, 32). Interestingly, this block in provirus expression is main-
tained upon differentiation of infected cells despite the fact
that primary infection of cells after differentiation results in
efficient expression (6, 7, 26).
Transcriptional repression is thought to be mediated by both
cis-acting de novo methylation of the integrated proviruses and
cell-type-specific trans-acting transcriptional repressors (5, 9,
23). The effect of trans-acting factors on retroviral expression
through binding of specific sequences within the promotors of
retroviruses has been examined in many studies (29, 30, 35). In
fact, the mouse stem cell virus (MSCV) long terminal repeat
(LTR) was generated by the modification of the sequences
within the LTR to increase the affinity for positive factors and
decrease the affinity for negative regulators (20).
In contrast, the role of methylation in silencing has been less
clear. DNA methylation is thought to be a general mechanism
used by cells to silence foreign DNA and may be involved in
the cell defense against transposable elements (39). DNA
methylation has also been associated with the repression of
gene expression and the silencing of viral control elements (2,
14, 38). Exogenously introduced retroviruses silenced in vitro
and in vivo can be reactivated by treatments that result in
genomewide demethylation. In addition, transcriptionally si-
lent endogenous retroviral elements are reactivated upon loss
of genomic methylation in Dnmt1 knockout mice (38). There-
fore, DNA methylation is thought to causally repress expres-
sion of retroviral promoters in a variety of cell types.
ES cells provide a good model to study the role of DNA
methylation in retroviral silencing. First, it was demonstrated
that ES cells have high de novo methylation activity, which
leads to effective methylation of integrated retroviral vectors,
while little or no de novo methylation activity was detected in
differentiated cells (21). In addition, ES cells were genetically
modified to alter the endogenous level of DNA methylation by
the targeted disruption of the maintenance methyltransferase
gene Dnmt1. ES cells homozygous for this mutation proliferate
normally with their genomic DNA highly demethylated, while
differentiated cells and mice die due to the loss of genomic
methylation (21, 22). Therefore, these modified ES cells are
useful to study the effect of DNA methylation on retroviral
gene expression. In addition, ES cells can be induced to dif-
ferentiate in vitro or in vivo, allowing the study of DNA meth-
ylation and its effect on long-term expression.
Both Moloney virus-based and MSCV-based retroviral vec-
tors have been used for gene transduction in a variety of cells.
The MSCV vector is different from the typical Moloney virus
vector in that the mutations in the LTR have allowed expres-
sion in a larger host range (8, 20). To this end, we modified
MSCV to express the green fluorescent protein (GFP) as a
sensitive reporter for gene expression (37). Using this vector,
we demonstrated efficient expression in both ES and HS cells.
We also demonstrated that silencing of retroviruses involves
two mechanisms: (i) trans-acting factors that affect the initial
expression of Moloney virus-based vectors but not MSCV-
based vectors and (ii) long-term DNA methylation-dependent
silencing that directly restricts expression of MSCV in ES cells
and during embryogenesis. Silencing of the MSCV vector in
wild-type ES cells and in in vivo differentiated ES cells was
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reversed by 5-azadeoxycytidine (5-azadC) treatments that de-
methylated the retroviral sequences, demonstrating that DNA
methylation directly controls the maintenance of retroviral re-
pression.
MATERIALS AND METHODS
Tissue culture. ES cells were cultured as described previously (21). To gen-
erate ES cell clones for injection into blastocysts, the ES cells were maintained
on irradiated mouse embryonic fibroblasts (MEFs) with 500 U of leukemia
inhibitory factor (LIF) per ml (22). For other experiments, the ES cells were
cultured without MEFs in 1,000 U of LIF per ml. 293 cells were maintained in
Dulbecco’s modified Eagle medium supplemented with 10% fetal bovine serum
(FBS), penicillin, streptomycin, and glutamine. Abelson virus-transformed B
cells were maintained in RPMI 1640 supplemented with 10% defined FBS
(HyClone), penicillin, streptomycin, glutamine, and 50 mM b-mercaptoethanol.
ES cells with retroviral integrants were in vitro differentiated as follows: the cells
were passaged without LIF in the absence of MEFs on bacterial plastic petri
dishes for 4 days, trypsinized, and cultivated with or without retinoic acid for 2
weeks (25).
Plasmids. The retroviral vectors MfgGFP, pMXGFP, and MSCViresGFP
have been described elsewhere (27, 33, 37). The MSCViresGFP vector was
modified by introducing either the Cre recombinase or the human Bcl-2 gene
upstream of the internal ribosome entry site (IRES)-GFP cassette as described
elsewhere (11, 37). The replication-incompetent helper plasmid pCL-eco was
used (24).
Retroviral infections. To generate retroviral supernatants, 293 cells were tran-
siently transfected by calcium phosphate-mediated coprecipitation with 5 mg of
the replication-incompetent helper vector pCL-eco and 10 mg of the reporter
retroviral vector as stated elsewhere (28). The cells were fed at 24 h postinfec-
tion, and the retroviral supernatant was used at 48 h. The cells continued to
produce high-titer retroviruses for another 2 days, and that supernatant was used
if needed for additional experiments. The supernatant was collected, brought to
4 mg of Polybrene per ml–10 mM HEPES, and filtered (0.45-mm-pore-size filter)
for use.
ES cells for infection were washed and trypsinized. They were then plated at
106 cells per well of a six-well dish and centrifuged. The ES cell medium was
removed, and retroviral supernatant was added at 1 ml/106 cells. Next, the plate
was centrifuged for 45 min at 2,500 rpm at room temperature. The retroviral
supernatants were removed; the cells were resuspended in ES cell medium and
plated onto gelatinized dishes. ES cells used to generate mice were plated onto
irradiated MEFs.
Bone marrow was infected as follows (36). C57BL/6 mice were obtained from
the Jackson Laboratory (Bar Harbor, Maine). Bone marrow cells were harvested
from the tibias and femurs of C57BL mice 5 days after they received an intra-
peritoneal injection of 5 mg of 5-fluorouracil (Sigma) in Dulbecco’s phosphate-
buffered saline (Gibco/BRL). These cells were then cultured for 4 days at 2 3 106
cells/ml with recombinant mouse interleukin-3 (rmIL-3; 20 ng/ml), rmIL-6 (50
ng/ml), and (50 ng/ml; recombinant mouse stem cell factor; R&D Systems) in
Dulbecco’s modified Eagle medium containing 10% FBS. After 48 and 72 h, the
bone marrow cells were spin infected with the retroviral supernatant generated
as described above. Then the retroviral supernatant was removed and replaced
with growth medium containing cytokines.
FACS (fluorescence-activated cell sorting) analysis and sorting. Adherent cell
lines were trypsinized, washed, and resuspended in complete medium to achieve
a single-cell suspension at the time points indicated. Nonadherent cells were
used directly for analysis. Organs were disrupted manually and passed through a
70-mm mesh to generate a single-cell suspension. The cells were analyzed for
viability using scatter properties and the exclusion of propidium iodide. The level
of GFP expression was monitored by fluorescence without compensation to
detect cells with low levels of GFP expression. The ES cells were sorted into ES
cell medium and plated immediately onto either gelatinized plates or MEFs for
blastocyst injections. The survival of ES cells after sorting was approximately
50%, as measured by the number of colonies generated divided by the expected
number of colonies.
5-AzadC treatments. ES cells were treated with 0.15 mM 5-azadC (Sigma) at
days 1 and 3 postplating. The cells were fed, allowed to recover, and then assayed
4 to 8 days later. The red blood cells in whole blood were lysed (5), and the
remaining cells were stained with fluorescently labeled anti-H2-b, anti-H2-d,
anti-B220, anti-TCRa (Pharmingen) at 1:200 as indicated. At day 0, splenocytes
were treated with either anti-CD3 or anti-CD40 (Pharmingen); 0.15 mM 5-azadC
was added at day 1, and the anti-CD3-treated cells were assayed at day 4.
5-AzadC was added again to the B-cell cultures with fresh anti-CD40 at day 4,
and the cells were assayed at day 6.
Staurosporine-mediated cell death. ES cells were infected with the stated
retrovirus and treated with staurosporine at day 4 postinfection for 24 h with the
indicated concentration of drug. The percentage of viable, GFP-positive cells was
determined by flow cytometry (6). Data are presented as a percentage of GFP-
positive cells before treatment. Results from one representative experiment of
three performed are shown.
LacZ staining. ES cells were infected with the stated retrovirus and sorted for
GFP expression at day 3 postinfection. The ES cells were plated and cultured for
an additional 5 days and stained for LacZ expression as described elsewhere (41).
Adoptive transfers. Recipient mice (10) received a total of 1,200 rads of
whole-body radiation in two doses (800 and 400 rads) 3 h apart and were then
injected with 2 3 106 to 5 3 106 infected bone marrow cells. Irradiated mice were
maintained on trimethaprim-sulfamethoxazole in sterile cages for 4 to 6 weeks to
prevent opportunistic infections (34). Serial passages were performed by har-
vesting bone marrow from mice 6 to 8 weeks postreconstitution and transferring
2 3 106 to 5 3 106 cells into irradiated recipients. Mice were analyzed 8 to 12
weeks posttransfer to allow reconstitution of the T-cell compartment. These
experiments were repeated multiple times with similar results.
Southern blot analysis. The genomic DNA was isolated as described else-
where (19). Ten micrograms of DNA was digested with the stated restriction
enzyme overnight. The products were resolved on an agarose gel, transferred to
a nylon membrane, and detected using a probe that spans the entire GFP coding
sequence.
RESULTS
High-efficiency retroviral expression in ES cells. Retroviral
vectors based on the MSCV LTR were constructed with a
multiple cloning site followed by an IRES driving expression of
the gene for GFP as schematically diagrammed in Fig. 1A
(MiG) (37). We generated high-titer retroviruses by transient
transfection and infected ES cells with an adapted spin infec-
tion protocol. Using this protocol, we reproducibly achieved
high-efficiency (.50%) infection of ES cells as measured by
flow cytometry; uninfected control cells were negative for GFP
expression (Fig. 1B). The intracellular concentration of GFP is
directly proportional to the fluorescence intensity measured by
flow cytometry.
Next, we compared expression of the MSCV-based retrovi-
rus and Moloney virus-based retroviral vectors in ES cells.
GFP expression was detectable with the MSCV LTR-contain-
ing MiG vector but not with the two Moloney virus-based
viruses pMX (27) and Mfg (33) (Fig. 1B). This was not due to
inefficient genomic integration of the provirus or to a lower
titer. Southern blot analysis of genomic DNA demonstrated
that all three proviruses were integrated in the ES cells (Fig.
1C). Also, when parallel B-cell cultures were infected with the
retroviral supernatant used to infect ES cells, all of the retro-
viral vectors were expressed in B cells at comparable efficien-
cies (Fig. 1B).
GFP expression driven by the MSCV LTR in ES cells was
substantially lower than in other differentiated cell lines tested
(Fig. 1B and data not shown) (20). To determine whether this
low level of expression was sufficient to drive functional ex-
pression of other gene products, we cloned the Cre recombi-
nase upstream of the IRES-GFP cassette to generate
MSCVCreiresGFP. We tested for Cre activity by infecting ES
cells that contain a translational stop sequence flanked by loxP
sites located between the Rosa 26 promoter and a lacZ re-
porter schematically diagrammed in Fig. 2A (34). If Cre is
expressed at functional levels in these ES cells, the protein will
catalyze recombination of the loxP sites, leading to loss of the
stop sequences and the expression of LacZ. Indeed, we found
that .99% of GFP-positive ES cells that were infected with
the Cre-expressing retrovirus were also LacZ positive (Fig.
2B). Uninfected cells were both GFP negative and LacZ neg-
ative (data not shown). This indicates that virus-mediated gene
transfer resulted in functional Cre expression.
Because Cre activity is required only transiently for LacZ
expression, we tested a second gene product that must be
stably expressed throughout the experiment. It has been dem-
onstrated that Bcl-2 expression protects many cell types against
staurosporine-mediated apoptosis (10). Therefore, we exam-
ined whether Bcl-2 could protect ES cells from apoptosis when
expressed from the MSCV LTR. We cloned human Bcl-2 up-
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stream of the IRES-GFP cassette to generate MSCV Bcl-
2iresGFP. Wild-type ES cells were infected with either the
Bcl-2-expressing retrovirus or the control virus lacking Bcl-2.
Increasing concentrations of staurosporine were added to the
cultures, and flow cytometry was used to assay for both viability
and GFP expression. GFP-positive cells infected with the Bcl-
2-containing virus were significantly protected from staurospo-
rine-mediated cell death compared to the GFP-negative cells
or GFP-positive cells infected with the control retrovirus (Fig.
2C). Therefore, the level of expression from the MSCV LTR is
sufficient for stable functional gene expression in ES cells.
Short-term transcriptional silencing in ES cells is methyl-
ation independent. It long has been hypothesized that retrovi-
ruses are transcriptionally silenced in embryonic cells by DNA
methylation (12, 14, 21). Therefore, it was possible that DNA
methylation of the MSCV LTR was responsible for the de-
creased level of expression in ES cells compared to other cell
types (Fig. 1B). In addition, we sought to test whether DNA
methylation of the Moloney virus-based vectors in the wild-
type ES cells was the mechanism by which the Moloney virus-
based LTRs were silenced (9, 13). To this end, we infected ES
cells deficient for the maintenance DNA methyltransferase
gene, Dnmt1, the loss of which results in genomewide hypo-
methylation (21, 22). Dnmt12/2 ES cells are demethylated, and
proviral sequences remain unmethylated. The Moloney virus-
based retroviruses such as pMX remained silent even when
FIG. 1. Efficient retroviral infection of ES cells. (A) Schematic diagram of
MiG vector containing the MSCV LTR followed by a multiple cloning site
(MCS) and an IRES-GFP cassette. (B) MSCV-based (MiG) but not Moloney
virus-based (Mfg and pMX) retroviruses express in ES cells. B cells or ES cells
were infected by the indicated retroviruses and assayed by flow cytometry 2 days
postinfection. Uninfected cells (unshaded) and infected cells (shaded area) were
electronically gated for live cells and subsequently analyzed for GFP fluores-
cence and for cell number. Percentages of GFP-positive cells are indicated. (C)
Comparable levels of integration of different retroviruses into ES cells, deter-
mined by Southern blot analysis of genomic DNA purified from infected and
uninfected ES cells 2 days postinfection, digested with KpnI, a restriction site
present within the LTRs, and probed with the GFP coding sequence.
FIG. 2. Expression from the MSCV LTR is sufficient to drive functional gene
expression. (A) Schematic diagram of the Rosa 26 locus in Cre reporter ES cells.
Before Cre-mediated recombination, LacZ expression is prevented by the pres-
ence of a stop fragment. Retroviral infection with a Cre-expressing retrovirus
with a GFP reporter results in two populations of cells. Cells that are GFP1
become LacZ1 due to efficient Cre-mediated recombination of the stop frag-
ment. In contrast, cells that are GFP2 were not infected and thus remained
LacZ2. (B) ES cells were infected with the MSCVCreiresGFP retrovirus and
sorted for either Gfp2 or Gfp1 as indicated. The cells were subsequently cul-
tured and stained for LacZ expression. Gfp2 cells are white (and therefore
LacZ2) while Gfp1 cells are blue (and therefore LacZ1). More than 99% of the
Gfp1 cells were LacZ1 in multiple experiments. (C) ES cells were infected with
either MSCViresGFP (n ) or MSCVBcl-2iresGFP (h) and treated with the
indicated amounts of staurosporine. The percentage of viable, Gfp1 (infected)
cells was determined by flow cytometry. The results are shown as a percentage of
Gfp1 cells before treatment. The results are from one representative experiment
of three performed.
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introduced into Dnmt12/2 ES cells, whereas MSCV expressed
similar levels of GFP in both Dnmt11/1 and Dnmt12/2 ES cells
(Fig. 3A). Therefore, the initial block in transcription directed
by Moloney virus LTRs in ES cells is independent of DNA
methylation and is presumably due to the binding of trans-
acting factors. In addition, the mean fluorescence intensities of
GFP were comparable between the Dnmt11/1 and Dnmt12/2
ES cells, indicating that the basal level of expression of the
MSCV LTR is independent of DNA methylation.
DNA methylation constrains long-term retroviral expression.
MiG-infected GFP-expressing ES cells were continually passaged
to test the effect of DNA methylation on long-term expression.
FIG. 3. Long-term expression of retroviruses is repressed by methylation. (A) MSCV-based (MiG) but not Moloney virus-based (pMX) retroviruses express in ES
cells independent of the methylation status of the cells. Dnmt11/1 or Dnmt12/2 ES cells were not infected (unshaded) or infected by the indicated retroviruses (shaded)
and assayed by flow cytometry 2 days postinfection as for Fig. 1B. (B) Long-term expression of GFP in ES cells is decreased in Dnmt11/1 cells but not Dnmt12/2 cells.
The ES cells were infected with MiG, passaged for 5 or 26 days postinfection, and assayed by flow cytometry as above. The mean fluorescent intensity for the population
and the percentage of GFP-positive cells are indicated. (C) Treatment with 5-azadC rescues the expression of retroviruses silenced by long-term passage. Dnmt11/1
or Dnmt12/2 ES cells were infected by MiG and passaged for .40 days. The cells were divided, and half were treated with 5-azadC. Then uninfected ES cells
(unshaded), MiG-infected untreated ES cells (dark shading), and MiG-infected 5-azadC-treated ES cells (light shading) were assayed by FACS analysis. Numbers below
the FACS plots are percentages of GFP-positive cells before and after 5-azadC treatment. (D) In vitro differentiation of ES cells does not affect retroviral expression.
A clonal ES cell line (R7) infected with MiG or an uninfected wild-type (WT) ES cell control was in vitro differentiated by passage without feeders and LIF, with or
without retinoic acid (RA) as indicated. The cells were assayed by flow cytometry, and the percentage of GFP-positive cells is indicated.
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Though GFP expression was high in both Dnmt12/2 and
Dnmt11/1 ES cells at 5 days postinfection, a substantial frac-
tion of the infected wild-type ES were GFP negative at 26 days
postinfection. This was apparent by both a loss in the percent-
age of GFP-positive cells as well as a decrease in the mean
fluorescence intensity of the bulk population of wild-type ES
cells and was observed in both bulk cultures and individual
cloned lines containing single integrants (Fig. 3B and data not
shown). The fraction of GFP-positive cells continues to de-
crease with additional passages, as shown in Fig. 3C. These
results suggest that long-term expression was suppressed by
DNA methylation. To directly test whether retroviral repres-
sion was due to de novo methylation of the newly integrated
retroviruses, we treated the long-term cultures with 5-azadC, a
drug that leads to hypomethylation of genomic DNA (16). If
DNA methylation was preventing expression of the MSCV
LTR, treatment with the drug should activate retroviral ex-
pression. Indeed, we found that 5-azadC treatment of ES cells
that had lost expression of GFP through long-term passage
reactivated the provirus (Fig. 3C). In contrast, Dnmt12/2 ES
cells infected with the retrovirus did not lose expression of
GFP; thus, treatment with 5-azadC did not significantly affect
retroviral expression (Fig. 3C). We also analyzed clonal lines
containing single proviral integrants in which GFP expression
was progressively silenced and found that treatment with
5-azadC resulted in the reactivation of gene expression in all
cases (data not shown). This demonstrates that DNA methyl-
ation controls long-term but not short-term expression of ret-
roviruses in ES cells.
Expression is maintained after in vitro differentiation. Pre-
viously, in vitro differentiation of ES cells had been demon-
strated to silence expression of retroviral sequences (12, 20).
Thus, we tested whether GFP expression from the MiG retro-
virus in ES cells was affected by in vitro differentiation. We
cultured MiG-infected wild-type ES cells in the absence of
embryonic feeder cells and LIF in suspension to generate em-
bryoid bodies. Disaggregated embryoid bodies were replated
either with or without retinoic acid. We found no change in
GFP expression in MiG-infected bulk cultures or individual
subclones containing one to several integrants upon in vitro
differentiation with either method, as shown for one clonal line
containing multiple integrants in Fig. 3D. GFP expression was
unchanged in all in vitro-differentiated ES cell lines, regardless
of whether the subclones contained only a single or multiple
integrants. This indicates that the MSCV-based MiG retrovi-
rus is not silenced by in vitro differentiation.
Generation of mice from GFP-expressing MiG-infected ES
cells. We next determined whether expression of the MSCV-
based MiG vector was affected by in vivo differentiation of the
infected ES cells. Cells from the chimeric animals were derived
by injection of MiG-infected wild-type ES cells (derived from
129-Sv/Jae mice) into BALB/c blastocysts. MiG-infected
Dnmt12/2 ES cells cannot be used for injection into blasto-
cysts, because Dnmt12/2 ES cells die upon differention and
therefore do not contribute significantly to adult mice (22).
MiG-infected wild-type ES cells were sorted for GFP expres-
sion by flow cytometry prior to injection, and two GFP-express-
ing clones, R2 and R11, were isolated (Fig. 4B). Southern blot
analysis demonstrated that R2 contained two integrants that
comigrate on an agarose gel, and R11 contained three proviral
integrants (Fig. 4A). High-contribution chimeras (.80% by
coat color) were generated from the R2 and R11 ES cells,
which transmitted the proviruses to their offspring (data not
shown).
To test whether the chimeras expressed the integrated ret-
roviruses, we isolated peripheral blood mononuclear cells
(PBMCs) from both the R2- and R11-derived chimeras. To
distinguish whether the PBMCs were derived from the ES cell
donor or the host blastocyst, we stained the cells with antibod-
ies that recognized specific major histocompatibility complex
class I haplotypes (Pharmingen). The donor ES cells (129
derived) are H2-b, and the blastocysts (BALB/C derived) are
H2-d (Fig. 4C and data not shown). In addition, we stained the
PBMCs with a pan-T-cell (TCRa) (Fig. 4C) or pan-B-cell
(B220) antibody (data not shown) to determine the ES cell
contribution to these lineages. Using this strategy, we found
that approximately 90% of the PBMCs from either the R2 or
R11 chimera were ES cell derived as measured by H2-b stain-
ing (Fig. 4C, data not shown). However, the majority of the
cells did not express GFP in either chimera (Fig. 4C and data
not shown). On the order of 0.1% of the PBMCs that were ES
FIG. 4. Retrovirally infected, GFP-expressing ES cells generated nonex-
pressing mice. (A) Two retrovirally infected clones sorted for GFP expression
were analyzed for proviral integrants by Southern blot analysis. R2 contained two
integrants, while R11 contained three. Uninfected cells are negative. (B) The
clones were passaged after sorting for GFP-expressing cells by flow cytometry
and reanalyzed for GFP expression. Both R2 and R11 express GFP (shaded)
compared to uninfected controls (unshaded). (C) PBMCs from the R2 chimera
(more than 50% contribution by coat color) were analyzed by flow cytometry. ES
cell contribution to the chimera was determined by phycoerythrin-H2-b staining
and cyc-TCRa staining and demonstrated contribution to the T-cell compart-
ment. The percentage of cells in each quadrant is listed. The cells were also
monitored for GFP expression. The percentage of GFP1 cells that are either
major histocompatibility complex (MHC) class I H2-b1 (ES cell derived) or
H2-b2 (blastocyst derived) is listed in the quadrant.
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cell derived were GFP positive, compared to less than 0.01%
that were blastocyst derived (Fig. 4C). Similar results were also
obtained with cells from the R11 chimera (data not shown).
The results indicate that the MSCV LTR is repressed during in
vivo differentiation to lymphocytes. Nevertheless, a small num-
ber of cells escaped silencing and expressed GFP. This tran-
scriptional repression of the MiG provirus in the chimeras is in
contrast to the GFP expression both in the donor ES and after
in vitro differentiation (Fig. 4B, data not shown).
To determine if other somatic cells expressed the retroviral
integrants, we analyzed the progeny of the chimeras. We iso-
lated spleen, thymus, kidney, and liver cells from an animal
carrying the two proviral integrants present in the R2 chimera
and a littermate control containing no retroviral integrants. We
analyzed these cells for GFP expression by FACS analysis and
found no detectable expression of GFP in the splenocytes,
thymocytes, renal cells, or hepatocyes (Fig. 5A and data not
shown).
In vitro reactivation of retroviral expression. One possible
explanation for transcriptional repression during in vivo differ-
entiation was de novo methylation of the integrated retroviral
LTR during embryonic development. To test this hypothesis,
we cultured splenocytes from a mouse containing the R2 pro-
viruses and from a littermate control, by treating the cells with
either anti-CD3 or anti-CD40 to activate and induce prolifer-
ation of the T cells or B cells, respectively (4). We then assayed
for GFP expression by flow cytometry and found that prolif-
eration of the splenocytes did not activate expression of the
retrovirus (data not shown). Next, we added 5-azadC to the
splenocyte cultures to induce demethylation of the retrovi-
ruses. Indeed, treatment with 5-azadC activated expression in
approximately 2% of the T cells (anti-CD3) (Fig. 5B) and 2%
of the B cells (anti-CD40) (data not shown). In addition, when
in vivo-differentiated cells, which had been isolated from the
kidney of a transgenic mouse and transformed with simian
virus 40 large T antigen (15), were treated with 5-azadC, acti-
vation of the silent provirus was observed in a similar fraction
of the cells (data not shown). The extent of reactivation of
expression of the provirus in in vivo-differentiated cells by
5-azadC was lower than in ES cells, where the reactivation of
the provirus with 5-azadC was almost complete.
We next determined whether demethylation of the retrovi-
rus in vivo would activate expression of the integrated retrovi-
ruses (13). Newborn mice were subcutaneously injected with
5-azadC at postnatal day 5 and subsequently analyzed at post-
natal day 14 for GFP expression by flow cytometry. We found
that 5-azadC-injected animals but not the uninjected controls
had activated GFP expression of the proviruses in the spleen,
thymus, and kidney (Fig. 5C and data not shown). When we
injected higher concentration of 5-azadC in an effort to further
demethylate the newborn mice, all injected animals died. This
result demonstrated that repression by DNA methylation is, at
least in part, responsible for silencing expression of the retro-
viral LTR in vivo.
Retroviral expression in HS cells after serial adoptive trans-
fers. Bone marrow contains the HS cells that can stably repop-
ulate the hematopoietic system after transfer to lethally irra-
diated mice. To determine whether HS cells can be effectively
transduced and express the MiG retrovirus, we used infected
bone marrow cells to reconstitute lethally irradiated mice (Fig.
6). We found that between 30 and 80% of the splenocytes from
these primary recipients expressed the retrovirus, as measured
by FACS analysis for GFP expression and shown for one rep-
resentative experiment (Fig. 6A). The MiG virus was expressed
in the B-cell, T-cell, and granulocyte compartments, as mea-
sured by a pan-B cell (B220), pan-T-cell (Thy-1), and pan-
granulocyte (Gr-1) marker electronically gated on GFP-posi-
tive cells (Fig. 6B and data not shown). Because a large
fraction of the splenocytes in the primary recipients are de-
rived from relatively differentiated, lineage-committed progen-
itors, serial adoptive transfers are required to test for retroviral
expression in the true HS cells (17). Therefore, we used bone
marrow from these primary recipients to serially reconstitute
lethally irradiated mice. This protocol requires substantial ex-
pansion from the stem cells and tests for long-term expres-
sion of the retrovirus. We observed no change in the per-
centage GFP-positive HS cells, and the level of GFP
expression from the adoptive transfers into multiple recip-
ients was stable over three additional passages (4° recipi-
ent). In addition, the infected cells gave rise to both B- and
T-cell lineages at the expected ratios (Fig. 6B), demonstrating
not only that the MiG retrovirus transduced the long-term
repopulating HS cells but also that the MiG-mediated GFP
expression was stable during in vivo hematopoietic differenti-
ation. However, our results do not exclude the possibility that
in addition to the transcriptionally active proviruses present
within these cells, there are also copies of the virus that were
transcriptionally silenced.
FIG. 5. Silenced retroviruses can be reactivated with 5-azadC. (A) Spleno-
cytes from an R21 or R22 littermate do not express GFP by flow cytometry.
Cells were stained with propidium iodide to exclude dead cells, and the percent-
age of GFP1 cells is indicated. (B) The splenocytes from panel B were induced
to proliferate with anti-CD3 and treated with 5-azadC. Cells were stained with
propidium iodide to exclude dead cells and analyzed by flow cytometry. The
percentage of GFP1 cells is indicated. (C) Flow cytometric analysis of the
splenocytes of littermates that were either uninjected or injected with 5-azadC at
passage 5 and analyzed at passage 14 for GFP expression. The percentage of
GFP1 splenocytes is indicated.
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DISCUSSION
We have investigated the role of DNA methylation in ret-
roviral silencing. Retrovirus-based studies of stem cells have
been hampered by the lack of expression. We have overcome
the transcriptional repression in ES cells by using an MSCV-
based vector in combination with a sensitive GFP reporter
gene (MiG vector). The analysis of expression of the MiG
vector and other Moloney virus-based vectors in Dnmt12/2
and Dnmt11/1 ES cells has allowed us to determine whether
DNA methylation directly controls retroviral gene expression
in these cells. We found that both methylation-dependent and
methylation-independent mechanisms exist to control retrovi-
ral gene expression.
Historically, retroviral expression of Moloney virus-based
vectors in ES cells has been negligible. In contrast, the MSCV
LTR not only transduces GFP expression in ES cells but also
expresses other exogenous gene products such as the Cre re-
combinase and the antiapoptotic factor Bcl-2 at detectable
level in ES cells. Therefore, the MSCV LTR can be used to
express various transgenes in ES cells and their differentiated
descendant cells.
It had been proposed that DNA methylation has evolved as
a cellular mechanism to silence retroviral elements, preventing
the spread of transposable elements through the genome (39).
Indeed, de novo methylation of integrated proviral sequences
has been observed in wild-type ES cells, which was correlated
with the transcriptional silencing of the retrovirus (14). Our
findings are the first demonstration that inhibition of the
Dnmt1 methyltransferase gene prevents silencing of the retro-
viruses in ES cells. This result provides direct evidence that
DNA methylation is causally involved in long-term retroviral
repression. Consistent with this conclusion is the demonstra-
tion that the transcriptionally silenced proviruses present in
long-term Dnmt11/1 ES cell cultures can be reversed by treat-
ments with 5-azadC.
In contrast, methylation-independent mechanisms deter-
mine initial retroviral expression in ES cells. Wild-type or
Dnmt12/2 ES cells infected with Moloney virus-based vectors
were transcriptionally silent, and therefore this silencing was
independent of the DNA methylation status of the cells. More-
over, the basal level of expression from the MSCV-based vec-
tor was unaffected by the methylation status of the cells. This
formally demonstrates that DNA methylation-independent
mechanisms control initial retroviral gene expression in ES
cells. Because the basal level of expression of the MSCV LTR
in ES cells is lower than in differentiated cell types and not
affected by the methylation status of the ES cells, trans-acting
factors must regulate the initial level of expression.
Previous studies found that retroviruses, including the
MSCV LTR, are silenced by the in vitro differentiation process
(20). In contrast, we found for the first time that expression of
this MSCV-based retrovirus in ES cells was maintained after in
vitro differentiation with and without retinoic acid. We were
also able to show long-term, stable GFP expression from the
MiG vector in HS cells and their differentiated derivatives.
MiG-mediated GFP expression from HS cells was stable
through serial adoptive transfers, and the HS cells gave rise to
GFP-expressing B- and T-cell lineages. Therefore, this MSCV-
based retroviral transduction system should allow for a molec-
ular analysis of stem cell biology and differentiation programs
by forced expression of exogenous gene products.
It has been postulated that methylation-dependent mecha-
nisms repress retroviral gene expression upon in vivo differen-
tiation (13, 20). To test this, we injected GFP-expressing un-
differentiated ES cells into recipient blastocysts and generated
chimeric mice. Differentiated tissues derived from these in
vivo-differentiated ES cells, such as PBMCs, lacked significant
GFP expression. Treatment of ES cell-derived differentiated
cells with 5-azadC in vitro or in vivo led to partial reactivation
of expression of the silenced retroviruses in lymphoid and
nonlymphoid tissues. We conclude from these results that the
maintenance of retroviral silencing in vivo involves DNA meth-
ylation. However, only a small fraction of the 5-azadC-treated
cells reactivated GFP expression, unlike the long-term ES cell
cultures, in which every cell reactivated GFP expression. This
suggests that methylation-independent mechanisms exist to
suppress retroviral expression. Alternatively, 5-azadC treat-
ment of differentiated cells, in contrast to ES cells, may not
lead to a level of genomic demethylation sufficient for com-
plete retroviral reactivation. The transgenic animals carrying
the silenced MiG proviruses will be a valuable indicator for in
vivo activation of GFP expression under different conditions.
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